New topical atopic dermatitis (AD) treatments may provide an alternative to topical corticosteroids (TCS), better treatment outcomes for moderate-to-severe atopic dermatitis, and an alternative to systemic antihistamines whose efficacy in AD is unproven and whose general use in AD management is discouraged by the American Academy of Dermatology. This according to a recent examination of trends in AD treatment over time. Visits for AD were identified in the 2003-2012 National Ambulatory Medical Care Survey (NAMCS). Investigators identified TCS, antibiotics (Abx), antihistamines (AH), topical calcineurin inhibitors (TCI), and systemic immunosuppressants (SI) prescribed at AD visits. They found:
- There were 990,000 annual visits for AD from 2003-2012 (3.2 visits/1000 people/year).
- TCS were the most frequently used medication (59% of visits).
- Topical calcineurin inhibitors (TCI) were the second most prescribed medication for AD among dermatologists (23% of visits), while antihistamines were second among all other physicians (16-44% of visits).
- Unlike other medications, use of TCIs decreased over time.
He A, Feldman SR, Fleischer Jr AB. Trends in atopic dermatitis management: Comparison of 1990-1997 to 2003-2012. J Drugs Dermatol. 2018;17(2):135-140.
This Week's Must Reads
Should Medical Coding Be Taught During Residency?, J Drugs Dermatol; 2018 Jun; Blecher, Halverstam, et al
Primary Closure Lengths in MMS Based on Cancer Type, Dermatolog Surg; ePub 2018 Jun 8; Theroux, et al
Citizen Pscientist: Important New Research Tool, Dermatol Ther (Heidelb); ePub 2018 Jun 6; Sanchez, et al
Acne Successfully Treated with Laser Combination, Dermatolog Surg; ePub 2018 Jun 5; Bakus, et al
FDA Approves Rituxan for Pemphigus Vulgaris, Genentech Web site; 2018 Jun 7
Must Reads in Atopic Dermatitis
Family Structure Linked with AD in US Children, J Am Acad Dermatol; ePub 2018 May 31; McKenzie, et al
Financial Burden of ED Visits for Atopic Dermatitis , J Am Acad Dermatol; ePub 2018 May 22; Kwa, et al
Trends in Atopic Dermatitis Management, J Drugs Dermatol; 2018 Feb; He, Feldman, et al
Use of Antihistamines for AD Treatment Evaluated, J Am Acad Dermatol; ePub 2018 Jan 6; He, et al
Atopic Dermatitis Linked with Serious Infections, Ann Allergy Asthma Immunol; 2018 Jan; Narla, et al